The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study - Université de Picardie Jules Verne Accéder directement au contenu
Communication Dans Un Congrès Année : 2016

The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study

Yoram Bouhnik
Fichier non déposé

Dates et versions

hal-03553395 , version 1 (02-02-2022)

Identifiants

  • HAL Id : hal-03553395 , version 1

Citer

Aurélien Amiot, Jean-Charles Grimaud, Xavier Treton, Jérôme Filippi, Benjamin Pariente, et al.. The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study. 11. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2016, Amsterdam, Netherlands. ⟨hal-03553395⟩
26 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More